StockNews.com Begins Coverage on Streamline Health Solutions (NASDAQ:STRM)

StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report released on Tuesday morning. The firm issued a sell rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of NASDAQ STRM opened at $2.78 on Tuesday. The firm’s 50-day moving average price is $2.62 and its 200-day moving average price is $5.34. Streamline Health Solutions has a 1-year low of $1.85 and a 1-year high of $9.75. The firm has a market capitalization of $11.73 million, a P/E ratio of -0.56 and a beta of 1.64. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66.

Streamline Health Solutions (NASDAQ:STRM) last posted its earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The business had revenue of $4.48 million during the quarter.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.